U.S. markets closed
  • S&P 500

    +1.77 (+0.03%)
  • Dow 30

    +62.42 (+0.16%)
  • Nasdaq

    -44.80 (-0.28%)
  • Russell 2000

    +2.85 (+0.14%)
  • Crude Oil

    -2.04 (-2.60%)
  • Gold

    +15.10 (+0.74%)
  • Silver

    +0.19 (+0.84%)

    -0.0005 (-0.04%)
  • 10-Yr Bond

    -0.0670 (-1.55%)

    +0.0015 (+0.12%)

    -0.0600 (-0.04%)
  • Bitcoin USD

    +87.66 (+0.17%)
  • CMC Crypto 200

    0.00 (0.00%)
  • FTSE 100

    +21.79 (+0.28%)
  • Nikkei 225

    +836.48 (+2.19%)

India OTC (Over-the-Counter) Drug Market Report 2023: Vitamins and Minerals Held the Largest Share (36.84%) of the Market in 2022 - Forecasts to 2027

Company Logo
Company Logo

Dublin, May 05, 2023 (GLOBE NEWSWIRE) -- The "OTC Drug Market in India 2023" report has been added to's offering.

The OTC drug market in India was valued at INR 448.19 Bn in 2022. It is expected to reach INR 1,080.08 Bn by 2027, expanding at a compound annual growth rate (CAGR) of ~19.35% during the 2023 - 2027 period.

OTC medications are used to treat minor illnesses. Patients choose their medications/brands for common mild diseases. Pharmacists can also recommend or advise patients on OTC drugs that do not fall under Schedule K of the Drugs and Cosmetics Act of 1940 or any other restrictive schedules for minor illnesses.

Market insights:

The Indian OTC drugs market has expanded rapidly in recent years, owing to factors such as a growing population, an expanding patient pool, and affordability.

The development of medical infrastructure, the introduction of patented drugs, and the emergence of new business models have all increased consumers' access to medicines. Vitamins and minerals held the largest share (36.84%) of the OTC drugs market in 2022. Cold and cough remedies are expected to grow rapidly as a result of recent drastic climate changes.

Market drivers:

People are more inclined to self-medicate by referring to information available on the internet as the country's use of the internet and social networks is growing. Furthermore, the use of various Vitamins and Mineral Supplements (VMS) in various formulations appeals to the health-conscious community, gaining traction in the OTC drug market.

Market challenges:

Antibiotics taken without prescription may result in resistance to antibiotics over time. Misuse or dependence on drugs such as sedatives, analgesics, antacids, and laxatives is another potential risk of a thriving but unregulated OTC market.

This could be hazardous for health as it will become difficult to treat infections if these drugs become less effective and it can occur due to lack of insights among consumers.

Key Topics Covered:

Chapter 1: Executive summary

Chapter 2: Socio-economic indicators

Chapter 3: Introduction
3.1. Market definition and structure
3.2. Online pharmacy landscape
3.3. Emergence of click and mortar model

Chapter 4: Market overview
4.1. OTC Drugs Market in India - An Overview
4.2. Market size and growth forecast (2021 - 2027e)

Chapter 5: Market segmentation
5.1. Share of OTC drugs (2022 and 2027e)

Chapter 6: Trade Analysis
6.1. Export (Based on value)
6.2. Import (Based on value)

Chapter 7: Impact of COVID-19
7.1. Impact of COVID-19

Chapter 8: Market influencers
8.1. Market drivers
8.2. Market challenges

Chapter 9: Competitive landscape
9.1. Alkem Laboratories Limited
9.2. Cipla Limited
9.3. Dr. Reddy's Laboratories Limited
9.4. Glenmark Pharmaceuticals Limited
9.5. Lupin Limited
9.6. MedPlus Health Services Limited
9.7. Apollo Pharmacies Limited
9.8. Emami Frank Ross Limited
9.9. 1mg
9.10. 91Streets Media Technologies Private Limited (PharmEasy)

Chapter 10: Competitive Benchmarking
10.1. Player benchmarking
10.2. Website benchmarking

Chapter 11: Recent developments

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: Laura Wood,Senior Press Manager For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900